Acrospire Investment Management LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$41,000
-73.5%
3,909
-76.7%
0.03%
-46.9%
Q4 2016$155,000
-48.5%
16,806
-34.1%
0.06%
-68.0%
Q3 2016$301,000
+36.2%
25,495
+49.1%
0.20%
+22.0%
Q2 2016$221,000
+130.2%
17,095
+184.9%
0.16%
+144.8%
Q1 2016$96,0006,0000.07%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders